Showing results (101-110 of 177) with videos related to
Sort By:
Pageof 18
Kidney International|August 17, 2012
Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patientsSophie Liabeuf, Aurélie Lenglet, Lucie Desjardins, et al.Kidney International|December 18, 2009
Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney diseaseDaniela V Barreto, Fellype C Barreto, Sophie Liabeuf, et al.Clinical Journal of the American Society of Nephrology : CJASN|February 6, 2010
The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary reportLeon J Schurgers, Daniela V Barreto, Fellype C Barreto, et al.The Journal of Neuropsychiatry and Clinical Neurosciences|July 27, 2018
Cognitive Impairments and Dysexecutive Behavioral Disorders in Chronic Kidney DiseaseLaurent Puy, Jean-Marc Bugnicourt, Sophie Liabeuf, et al.Clinical Kidney Journal|August 31, 2017
Infectious complications of a rituximab-based immunosuppressive regimen in patients with glomerular diseaseClaire Trivin, Antoine Tran, Bruno Moulin, et al.Journal of Internal Medicine|April 25, 2022
Iron deficiency screening is a key issue in chronic inflammatory diseases: A call to actionPatrice Cacoub, Gabriel Choukroun, Alain Cohen-Solal, et al.Nutrients|March 10, 2022
Towards a Common Definition for the Diagnosis of Iron Deficiency in Chronic Inflammatory DiseasesPatrice Cacoub, Gabriel Choukroun, Alain Cohen-Solal, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 24, 2007
Insulin maintains plasma antioxidant capacity at an early phase of kidney transplantationMatthieu Monge, Nelly Ledemé, Hakim Mazouz, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 17, 2009
Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney diseaseSophie Liabeuf, Daniela V Barreto, Fellype C Barreto, et al.Toxins|May 22, 2019
The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical TrialYoussef Bennis, Yan Cluet, Dimitri Titeca-Beauport, et al.Pageof 18